Chinese pharma BrightGene has reported that it has successfully copied remdesivir, an experimental therapy which has shown promise against the novel coronavirus.
In a highly unusual step, a Chinese company said it has begun mass producing an experimental Gilead drug that US doctors used to treat patients infected with the novel coronavirus.
Brightgene Bio-Medical`s Generic Entecavir Receives Approval In US